Objective The purpose of this study was to assess the value of 2-[F-18]fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography ([F-18]FDG PET/CT) in the primary staging of high-risk endometrial cancer patients. Methods This retrospective study was conducted on 32 consecutive patients with histological diagnosis of primary high-risk endometrial cancer, who underwent PET/CT with [F-18]FDG in addition to conventional clinical and instrumental staging procedures. After surgery, [F-18]FDG PET/CT findings were correlated with pathological findings on a patient-by-patient basis. The diagnostic accuracy of [F-18]FDG PET/CT for primary cancer detection, lymph nodal involvement and distant metastases was assessed. Results [F-18]FDG PET/CT could correctly detect primary tumor in 29 of the 32 high-risk patients, with a sensitivity of 90.6%. The overall [F-18]FDG PET/CT patient-based sensitivity, specificity, positive predictive value, negative predictive value and accuracy were 57.1, 100.0, 100.0, 86.4, and 88.5%, respectively, for revealing lymph nodal neoplastic involvement, and 100.0, 96.0, 87.5, 100.0, 96.9%, respectively, for detecting distant metastases. In particular, while the suspicion of distant metastases was documented by conventional imaging in only two patients, [F-18]FDG PET/CT correctly identified metastatic lesions in seven patients (21.9% of cases). Conclusion The major benefit provided in high-grade tumor patients by the use of [F-18]FDG PET/CT in the primary staging of endometrial cancer is its ability to accurately detect distant metastases in the abdomen and extra-abdominal regions. [F-18]FDG PET/CT adds relevant information that may influence patient management. Nucl Med Commun 31: 506-512 (C) 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins.
High-grade endometrial cancer: value of [F-18]FDG PET/CT in preoperative staging / Picchio, M; Mangili, G; Gajate, Ams; De Marzi, P; Spinapolice, Eg; Mapelli, P; Giovacchini, G; Sigismondi, C; Vigano, R; Sironi, S; Messa, C. - In: NUCLEAR MEDICINE COMMUNICATIONS. - ISSN 0143-3636. - 31:6(2010), pp. 506-512. [10.1097/MNM.0b013e328337cb47]
High-grade endometrial cancer: value of [F-18]FDG PET/CT in preoperative staging
Picchio M;Mapelli P;
2010-01-01
Abstract
Objective The purpose of this study was to assess the value of 2-[F-18]fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography ([F-18]FDG PET/CT) in the primary staging of high-risk endometrial cancer patients. Methods This retrospective study was conducted on 32 consecutive patients with histological diagnosis of primary high-risk endometrial cancer, who underwent PET/CT with [F-18]FDG in addition to conventional clinical and instrumental staging procedures. After surgery, [F-18]FDG PET/CT findings were correlated with pathological findings on a patient-by-patient basis. The diagnostic accuracy of [F-18]FDG PET/CT for primary cancer detection, lymph nodal involvement and distant metastases was assessed. Results [F-18]FDG PET/CT could correctly detect primary tumor in 29 of the 32 high-risk patients, with a sensitivity of 90.6%. The overall [F-18]FDG PET/CT patient-based sensitivity, specificity, positive predictive value, negative predictive value and accuracy were 57.1, 100.0, 100.0, 86.4, and 88.5%, respectively, for revealing lymph nodal neoplastic involvement, and 100.0, 96.0, 87.5, 100.0, 96.9%, respectively, for detecting distant metastases. In particular, while the suspicion of distant metastases was documented by conventional imaging in only two patients, [F-18]FDG PET/CT correctly identified metastatic lesions in seven patients (21.9% of cases). Conclusion The major benefit provided in high-grade tumor patients by the use of [F-18]FDG PET/CT in the primary staging of endometrial cancer is its ability to accurately detect distant metastases in the abdomen and extra-abdominal regions. [F-18]FDG PET/CT adds relevant information that may influence patient management. Nucl Med Commun 31: 506-512 (C) 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.